Technology, Healthcare Jan 24, 2022 09:39 PM (GMT+8) · EqualOcean
Fuxiang pharmaceutical announced that the net profit attributable to the parent company in 2021 is expected to be 43.8 million yuan - 63.8 million yuan, a year-on-year decrease of 80.02% - 86.28%. Due to the sharp rise in the price of raw materials of the company's main products, the company's procurement cost has increased significantly; At the same time, affected by market demand, epidemic situation and other factors, the sales volume and price of some products decreased year-on-year, resulting in reduced profits.

This text is a result of machine translation.